The Efficacy of Transarterial Chemoembolization plus Apatinib or Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma.

Lei ChenTao SunLinxia WuWeihua ZhangYanqiao RenDongqiao XiangBin Liang Chuangsheng Zheng

Published in: Journal of oncology (2021)

Patients with advanced hepatocellular carcinoma could get similar survival benefits from treatment with either transarterial chemoembolization plus apatinib or transarterial chemoembolization plus sorafenib.

Keyphrases

radiofrequency ablation
liver metastases
combination therapy